12.07.2015 Views

Substance Abuse in WV - West Virginia State Medical Association

Substance Abuse in WV - West Virginia State Medical Association

Substance Abuse in WV - West Virginia State Medical Association

SHOW MORE
SHOW LESS
  • No tags were found...

Create successful ePaper yourself

Turn your PDF publications into a flip-book with our unique Google optimized e-Paper software.

Special Issue | Scientific Articlestimulation <strong>in</strong>clud<strong>in</strong>g “vibration <strong>in</strong>the area of pa<strong>in</strong>.” He was then given<strong>in</strong>formed consent, was educatedregard<strong>in</strong>g the procedure, and wasevaluated for preoperative anesthesiaand sedation. He then underwentan outpatient SCS temporaryimplant. After receiv<strong>in</strong>g <strong>in</strong>travenousvancomyc<strong>in</strong> preoperatively, he wastaken to the operat<strong>in</strong>g theatre andplaced <strong>in</strong> the proper prone positionand prepped and draped <strong>in</strong> sterilefashion. Fluoroscopic imag<strong>in</strong>g wasused to identify the sp<strong>in</strong>e, and theappropriate anatomic landmarks.A laser guided approach wasused to guide the needle to theepidural space to give access forlead placement. The trial leads wereplaced via a m<strong>in</strong>imally <strong>in</strong>vasive,percutaneous approach, <strong>in</strong>to thethoracic sp<strong>in</strong>e with a target area ofT8 to T12. These targets were basedon previous mapp<strong>in</strong>g which suggeststhese are the sp<strong>in</strong>al regions bestimpacted to produce paresthesia <strong>in</strong>the areas of pa<strong>in</strong>. (See figures 1, 2)The leads were left <strong>in</strong> place for afive day trial period at which timethe result<strong>in</strong>g paresthesia led to areduction of pa<strong>in</strong> of 70%. The leadswere removed <strong>in</strong> the office on dayfive. The patient wished to moveforward with the permanent implant.Two weeks after the orig<strong>in</strong>al trialthe patient underwent reimplantationof the percutaneous leads <strong>in</strong> thesame target zone as the orig<strong>in</strong>alimplant. A cutdown was then createdto the sp<strong>in</strong>al fascia and ligaments.Fatty tissue was debrided and theneedle and stylet were removed. Atthis po<strong>in</strong>t, non-absorbable suturewas used to anchor the leads tothe sp<strong>in</strong>al ligaments and fascia. Asubcutaneous pocket was made <strong>in</strong>the area just above the beltl<strong>in</strong>e, anda tunnel<strong>in</strong>g rod was used to tunnelthe leads from the midl<strong>in</strong>e <strong>in</strong>cisionto the pocket. The device was thenconnected to the rechargeable batterywith a hex wrench, and computerprogramm<strong>in</strong>g was <strong>in</strong>itiated bywireless telemetry. (See s 3, 4, 5)The patient underwent a six weekrecovery period to allow the leads tostabilize and scar <strong>in</strong>to the tissue. Atthis po<strong>in</strong>t the patient was placed <strong>in</strong>toa comprehensive twelve week sp<strong>in</strong>alrehabilitation program with goals ofimprov<strong>in</strong>g strength and muscle mass,improv<strong>in</strong>g flexibility and rega<strong>in</strong><strong>in</strong>ghis functional status. At his one yearfollow up he had totally weanedfrom all controlled substances,returned to work as a sky div<strong>in</strong>g<strong>in</strong>structor and was matriculat<strong>in</strong>g<strong>in</strong> an advanced college program.Discussion and LiteratureReviewSp<strong>in</strong>al cord stimulation is am<strong>in</strong>imally <strong>in</strong>vasive therapy that3000 Wash<strong>in</strong>gton St. <strong>West</strong>is used for <strong>in</strong>tractable moderate tosevere pa<strong>in</strong> of neuropathic orig<strong>in</strong>.Patients are selected based on failureof reasonable conservative therapies,and the absence of untreatedbleed<strong>in</strong>g disorders, or active systemic<strong>in</strong>fection. The patient’s outcomeFigure 1.Lead position as viewed under fluoroscopy.Figure 2.Lead placement.SUBSTANCE ABUSE IN <strong>WV</strong> | Vol. 106 57

Hooray! Your file is uploaded and ready to be published.

Saved successfully!

Ooh no, something went wrong!